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ARTICLE
De novo design of a reversible phosphorylation-
dependent switch for membrane targeting
Leon Harrington 1, Jordan M. Fletcher2, Tamara Heermann 1, Derek N. Woolfson 2,3,4✉ &
Petra Schwille 1,4✉
Modules that switch protein-protein interactions on and off are essential to develop synthetic
biology; for example, to construct orthogonal signaling pathways, to control artificial protein
structures dynamically, and for protein localization in cells or protocells. In nature, the E. coli
MinCDE system couples nucleotide-dependent switching of MinD dimerization to membrane
targeting to trigger spatiotemporal pattern formation. Here we present a de novo peptide-
based molecular switch that toggles reversibly between monomer and dimer in response to
phosphorylation and dephosphorylation. In combination with other modules, we construct
fusion proteins that couple switching to lipid-membrane targeting by: (i) tethering a ‘cargo’
molecule reversibly to a permanent membrane ‘anchor’; and (ii) creating a ‘membrane-avidity
switch’ that mimics the MinD system but operates by reversible phosphorylation. These
minimal, de novo molecular switches have potential applications for introducing dynamic
processes into designed and engineered proteins to augment functions in living cells and add
functionality to protocells.
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The reversible switching of molecular states is ubiquitous innature, enabling the dynamic regulation of cellular pro-cesses essential for life such as cell signaling, transcriptional
regulation, and cell division1. Such switching may be achieved
through conformational change or changes in oligomeric state,
which are typically induced by post-translational modification or
cofactor binding.
Considerable effort has been made to harness and engineer
such natural ‘molecular switches’ in vitro2–4. Increasingly, there is
a demand to create de novo switches that are orthogonal to
existing cellular systems, that enable regulation by different forms
of stimuli, and that operate in more-complex environments such
as in cells and at membranes. Such artificial molecular switches
are important for the development of bioengineering and syn-
thetic biology, as they would allow new regulatory mechanisms
and circuits to be incorporated into host cells, or synthetic ‘proto-
cells’, endowing their host compartments with new, dynamic
functionality4.
Examples of engineered molecular switches include those
that respond to small-molecule ligands, usually by triggering
dimerization of two protein domains5–7. Recently, light-
operated molecular switches have been designed that allow
‘optogenetic’ control of cellular processes8. For example, the
LOV2 domain of Avena sativa can be harnessed to create
photodimerizing domains such as the iLID9, TULIP10, and
LOVTRAP11 systems. Exposure to blue light induces a con-
formational change in the LOV2 domain that is coupled to
drive heterodimerization in the case of iLID and TULIP, or
dissociation in the case of LOVTRAP. These processes are
reversible in the dark.
Another important molecular switch that has been less-
extensively pursued is for reversible membrane-targeting, i.e.,
switching between membrane-bound and solution states. Such
switching is common in dynamic, non-linear biological systems
as the difference in diffusion coefficients for membrane-bound
and cytoplasmic fractions allows a key criterion for reaction-
diffusion mechanisms to be met12. The ability to tether a mole-
cular cargo to a cellular or artificial membrane reversibly also has
important applications in biotechnology and synthetic
biology13,14.
Natural examples of reversible membrane binding include the
E. coli MinCDE system15,16 and the eukaryotic Rho GTPase
Cdc4217. In the former, MinD switches repeatedly between a
membrane-bound dimer and a cytoplasmic monomer in response
to ATP binding and hydrolysis. The membrane affinity of the
dimer is enhanced substantially by the avidity effect of bearing
two copies of a short, amphipathic membrane-targeting
sequence18,19. This shuttling between membrane-bound and
solution states is an essential aspect of the mechanism that
enables the MinCDE system to exhibit spatiotemporal oscillation
and pattern formation in vivo and when reconstituted in vitro on
artificial membranes15,16.
Taking inspiration from natural molecular switches and the E.
coli Min system, we sought to design a minimal de novo
protein–protein interaction (PPI) module that could then be
coupled to membrane-targeting peptides to achieve a system that
reversibly switches between membrane-bound and solution states
in response to a stimulus. We chose protein phosphorylation and
dephosphorylation as the stimulus. In nature, reversible protein
phosphorylation is a particularly powerful means of dynamically
switching PPIs, for example in the regulation of transmembrane
receptors20. As these modifications are carried out by a large
diversity of enzymes (kinases and phosphatases) working in
opposition, complex signaling pathways with multiple points of
regulation can be formed that respond rapidly to regulatory
signals.
Previous design studies have shown that phosphorylation can
be harnessed to alter metal-binding properties of small
peptides21,22, control the assembly of peptide-based hydrogels23,
and to stabilize peptide oligomers in the phosphorylated
state24,25, or alternatively destabilize them26. The use of small
peptide ‘modules’ for the design and engineering of molecular
switches is particularly attractive, as many existing systems use
larger protein domains the size of which may interfere with the
function of fusion domains or cause undesirable trafficking and
localization in cellular contexts. However, examples to date have
repurposed existing natural motifs, such as Ca2+-binding EF
hands, bZIP domains, or the Lac repressor tetramerization
domain21,24,25. To engineer truly orthogonal circuits and enable
fully deterministic engineering of PPIs, it is desirable to use
synthetic peptide sequences that eliminate any possibility of
cross-talk or cryptic function. Indeed, others have described de
novo designed peptides and proteins that switch in response to
heat27, the reduction of disulfide bonds28, metal binding29,30, and
changes in pH31,32.
Here, we present a molecular switch based on a de novo
designed heterodimeric coiled-coil (CC) assembly33, which we
engineer to switch dynamically between monomeric and dimeric
states by phosphorylation and dephosphorylation. CC peptides
are ideal for this purpose, as the rules relating to their folding are
relatively well understood, allowing rational design at the amino
acid sequence level34,35. In addition, stable CC dimers can be
achieved with relatively short peptides, enabling the design of
minimal, switchable interaction modules. The resulting CC-based
interaction modules of our molecular switch can be coupled to
membrane-targeting sequences to create a membrane-targeting
switch operated by phosphorylation and dephosphorylation. In
addition to the important application of dynamically functiona-
lizing membranes, we anticipate that the CC-based molecular
switches described here will be highly useful for the engineering
of transcriptional regulation and construction of orthogonal,
protein-based circuits in both natural and artificial cells36–40.
Results
Design of CC peptides for molecular switching. For the CC-
based design, we began with the well-characterized de novo
parallel heterodimeric coiled coil, CC-Di-AN4BN4 (Table 1)33.
CC-Di-AN4BN4 exhibits cooperative ‘off-on’ folding and assem-
bly; i.e., the individual peptides remain unfolded and do not form
homodimers by themselves (due to interhelical electrostatic
repulsion), whereas the two complementary peptides form a
characteristically folded coiled-coil heterodimer when mixed. Our
aim was to incorporate the recognition motif of the Ser/Thr
cAMP-dependent protein kinase (PKA) into just one of the
peptides and to complement it with a variant of the other. We
hypothesized that phosphorylation of the introduced Ser would
disrupt the close packing of the CC interface and prevent
dimerization, whereas, with appropriate redesign, the unpho-
sphorylated state should assemble (Fig. 1a).
As PKA is a basophilic kinase, we incorporated the recognition
motif (RRXS/T, where X is any amino acid) into the basic peptide
(CC-Di-BN4). The recognition motif was placed such that the
phospho-acceptor residue (Ser) was at the a position of the
second heptad repeat (abcdefg) of the four-heptad peptide
sequence (Fig. 1a and Table 1). We reasoned that: (i) a sites are
in the helix–helix interface and their modification would
maximize the impact of phosphorylation to induce CC disas-
sembly; (ii) a sites of dimeric CCs tolerate substitutions more
than the alternative d sites41; and (iii) the polar Arg-Arg residues
of the RRXS/T motif would be best accommodated at the e and f
sites, which are furthest away from the helix-helix interface
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(Fig. 1a). The resulting peptide is referred to as CC-Di-B_RRS
hereafter (Table 1).
Next, we considered appropriate side chains to place at the
corresponding a′ position of the acidic partner peptide. In
general, it is to be expected that there will be a trade-off between
having suffiicient stability for strong ‘off-on’ switching, and
sufficient lability to render the switch reversible. The canonical
residue at a in natural coiled coils is Ile41,42, and this is used
widely in designs including CC-Di-AB33. Indeed, the most
stabilizing pair at a–a′ sites in CC dimers is Ile-Ile41,42. Thus,
the introduction of the PKA recognition site was already
anticipated to destabilize the CC. Energetic analysis confirms
that Ser at a is destabilizing relative to Ile-Ile, and that Ser-Ile is
the least destabilizing of the remaining combinations42.
Table 1 Sequences of de novo designed coiled-coil peptides.
The bold letters indicate key residues mutated.
The colour code is to aid visual comparison with the correspondingly coloured elements of Fig. 1.
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Fig. 1 Design and solution-phase characterization of phosphorylation-switchable coiled-coil heterodimers. a Helical wheels for the (i) parent and (ii)
CC-Di-A_S:CC-Di-B_RRS coiled-coil (CC) designs, and (iii) illustration of the switching concept. In its unphosphorylated state, CC-Di-B_RRS (blue) forms a
heterodimeric CC with CC-Di-A_S or CC-Di-AN4 (red). Phosphorylation of CC-Di-B_RRS by a protein kinase (e.g. PKA) prevents this dimerization due to
the bulk and charge of the phosphoryl moiety. Dephosphorylation by a protein phosphatase (e.g. lambda protein phosphatase) re-enables dimerization.
b CD spectra of individual peptides and their combinations acquired at 25 °C in phosphate-buffered saline (PBS) at pH 7.4: blue, CC-Di-A_S; orange, CC-
Di-AN4; green, CC-Di-B_RRS; red, CC-Di-A_S:CC-Di-B_RRS; and purple, CC-Di-AN4:CC-Di-B_RRS. c Thermal unfolding curves of individual peptides and
their combinations in PBS at pH 7.4. The concentration of each peptide was 50 μM in all CD experiments.
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Considering the next expected ‘least-worst’ combination, Ser
when paired with polar residues at a′ prefers the homotypic
Ser–Ser pairing42. Therefore, to span this range, we prepared two
acidic peptides (Table 1): the original parent, CC-Di-AN4, which
has Ile at the a′ site corresponding to the Ser at a in CC-Di-
B_RRS; and CC-Di-A_S, where that Ile is replaced by Ser. These
were combined with the basic peptide CC-Di-B_RRS to
determine which pairing was optimal for switching.
To allow rapid characterization of our CC modules, the
peptides CC-Di-AN4, CC-Di-A_S, and CC-Di-B_RRS were
synthesized by solid-phase peptide synthesis and purified.
Circular dichroism (CD) spectroscopy confirmed that the
individual peptides were not folded, whereas CD spectra for
both CC-Di-AN4:CC-Di-B_RRS and CC-Di-A_S:CC-Di-B_RRS
were characteristic of fully folded α-helical structures, and
consistent with heterodimer formation (Fig. 1b). Next, we
compared the stabilities of the two hetero-assemblies using
thermal unfolding followed by CD spectroscopy (Fig. 1c). As
anticipated, the Ser–Ser pairing at a–a′ was less stable than
Ile–Ser (TM= 54 °C vs 73 °C, respectively), but both combina-
tions were destabilizing relative to the parent heterodimer, CC-
Di-AN4BN4 (TM= 81 °C)33,42.
Phosphorylation-induced switching of the CC modules is sta-
bility dependent. The kinetics of phosphorylation of the CC-Di-
B_RRS peptide on its own and when associated with CC-Di-A_S
or CC-Di-AN4 were followed by analytical high-performance
liquid chromatography (HPLC), Fig. 2. The phosphorylated form,
CC-Di-B_RRpS, eluted before CC-Di-B_RRS due to the presence
of the more-polar phosphoserine residue (Supplementary Fig. 1).
CC-Di-B_RRS alone was phosphorylated rapidly by PKA, with
the reaction reaching completion after 10 min (Fig. 2a, b and
Supplementary Fig. 1). The mean rate constant for product for-
mation (kprod) was 0.20 ± 0.07 min–1, and that for substrate
consumption (ksubs) was 0.23 ± 0.08 min–1 (both n= 3; errors
reported for mean values are standard deviations throughout
unless otherwise indicated). In contrast, phosphorylation of the
peptide in the presence of CC-Di-A_S was ≈25–50 times slower:
kprod= (8.0 ± 0.6) × 10–3 min–1, and ksubs= (4.2 ± 0.2) × 10–3
min–1 (both n= 3; p < 0.0001). With CC-Di-AN4 as the partner
peptide, phosphorylation was extremely slow (by approximately
two to three orders of magnitude compared with the free peptide)
and did not reach completion even after 24 h (Fig. 2a, b and
Supplementary Fig. 1). As discussed below, these kinetic
differences are likely due to differences in temporal accessibility of
the phosphorylation site via the unfolded state, and, thus, related
to the overall stability of the CC complex.
To complement the HPLC experiments and to characterize the
effect of phosphorylation on the assembled CCs, we followed
phosphorylation over time by CD spectroscopy monitoring the
change in mean residual ellipticity at 222 nm (MRE222), which
reports directly on helicity. Phosphorylation led to a loss of
helicity, suggesting that the CC peptides were indeed switching to
disassembled monomeric states. We verified that there was no
contribution to the CD signal from the kinase (Supplementary
Fig. 2a).
The kinetics of this process were consistent with those derived
from the HPLC data, with k= (9 ± 2) × 10–3 min–1 (n= 3) for
CC-Di-A_S:CC-Di-B_RRS at 25 °C; and k= (8 ± 1) × 10–2 min–1
(n= 3) for the same at 37 °C (Fig. 2c and Supplementary Fig. 2b,
c). We also performed kinetic CD experiments with triple the
amount of PKA. For CC-Di-A_S:CC-Di-B_RRS at 25 °C there
was a ≈1.7-fold increase, with k= (15 ± 1) × 10–3 min–1 versus k
= (9 ± 2) × 10–3 min–1 (both n= 3).
To confirm that the end-point CD spectrum was due to the
presence of the phosphorylated product, we prepared CC-Di-
B_RRpS by solid-phase synthesis and obtained its CD spectrum
with CC-Di-A_S. This was indeed found to be comparable with
the end-point spectrum for the phosphorylation reaction of CC-
Di-A_S:CC-Di-B_RRS (Supplementary Fig. 3a, b). We also
obtained the CD spectrum of CC-Di-B_RRpS in the presence
of CC-Di-AN4, which exhibited some helicity that may be due to
formation of a partial CC (Supplementary Fig. 3c).
Finally, we mixed CC-Di-B_RRpS with CC-Di-A_S and
measured CD spectra before and after the addition of lambda
protein phosphatase (λPP) and MnCl2. An increase in helicity
was observed after the addition of λPP, consistent with depho-
sphorylation of CC-Di-B_RRpS and formation of CC-Di-A_S:
CC-Di-B_RRS (Supplementary Fig. 4).
In view of the observed differences in phosphorylation kinetics
of CC-Di-B_RRS alone and with the different partners, we
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Fig. 2 Kinetics of phosphorylation-induced dissociation. Representative phosphorylation reaction time courses for a product (CC-Di-B_RRpS) formation,
and b substrate (CC-Di-B_RRS) consumption, determined by analytical HPLC. Time courses are shown for reactions consisting only of CC-Di-B_RRS (blue);
or CC-Di-B_RRS in the presence of CC-Di-A_S (orange) or CC-Di-AN4 (green). c Representative phosphorylation time courses determined by CD
spectroscopy for CC-Di-B_RRS in the presence of CC-Di-A_S at 25 °C and 37 °C (blue and orange) and CC-Di-AN4 at 25 °C and 37 °C (green and red).
Each peptide was at 50 µM concentration, and reactions were performed in PBS at pH 7.4 supplemented with 10 mM MgCl2 and 1 mM ATP. cAMP-
dependent protein kinase (PKA, 8.33 U µL−1 of reaction) was added to initiate phosphorylation. Reactions for analytical HPLC were all performed at 25 °C.
All reactions were performed in triplicate.
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site is inaccessible when the peptides are assembled as CCs, and
that only the monomeric fraction is modified.
In this scheme, phosphorylation depletes B (CC-Di-B_RRS)
shifting the reaction to the right until all B is converted into B′
(CC-Di-B_RRpS). The larger the pool of available B, the faster the
initial reaction. This pool is determined by the dissociation
constant of A—B. Thus, we expect that the reaction will proceed
faster with weaker A–B complexes. This is precisely what we
observed: in the presence of CC-Di-A_S the reaction was faster
than with CC-Di-AN4 (Fig. 2). These results suggest that the
kinetics of the switching process can be tuned at the amino-acid
level by varying the stability of the CC complex, as well as by
peptide concentration and temperature. We chose the CC-Di-
A_S:CC-Di-B_RRS combination for further use as it exhibited
faster kinetics and well-defined monomer/dimer switching
compared to CC-Di-AN4:CC-Di-B_RRS.
Phosphorylation and dephosphorylation reversibly tethers a
cargo molecule to a membrane anchor. To use the CC switch for
reversible membrane targeting, we began by designing a simple
proof-of-concept comprising two components: a permanently
Fig. 3 Reversible membrane tethering of a cargo peptide to an anchor protein. a Illustration of reversible membrane tethering on Supported Lipid Bilayers
(SLBs) with CC-Di-A_S in red, CC-Di-B_RRS in blue, and Alexa Fluor 594 (AF594) in pink. b Representative kinetics of phosphorylation-induced release of
the cargo peptide (AF594-CC-Di-B_RRS, pink line) from the anchor protein (CC-Di-A_S-mCitrine-H10, orange line). Phosphorylation was initiated with
PKA (cAMP-dependent protein kinase) and MgATP and reversed by lambda protein phosphatase (λPP) and MnCl2. Experiments were performed in
triplicate. Plotted fluorescence intensities (arbitrary units) are peak intensities (i.e., membrane localized), determined from z-axis fluorescence intensity
profiles such as those shown in c–e. Values corresponding to the cargo peptide were fitted with the function y ¼ y0 þ ðy1  y0Þð1 ekxÞ. Values for the
anchor protein were fitted with the function y= k. Representative xz plane confocal images from z-stacks are shown together with fluorescence z-profiles
and illustrative schematics for: c CC-Di-A_S-mCitrine-H10 and AF594-CC-Di-B_RRS on an SLB; d the system of c 70min after the addition of PKA;
e the system of d after adding λPP. f Quantitation of membrane binding of CC-Di-A_S-Citrine-H10 (orange) and AF594-CC-Di-B_RRS (pink) under
the conditions of c–e, calculated from fluorescence z-profiles (n= 3 independent experiments; error bars represent mean ± S.D.; *p= 0.005, t= 5.6127;
†p= 0.009, t= 4.7414; unpaired two-tailed t test). SLBs were DOPC with 2 mol% DGS-NTA(Ni2+) and 0.1 mol% ATTO655-DOPE. AF594-CC-Di-B_RRS
and CC-Di-A_S-mCitrine-H10 were both at 1 µM. The SLB buffer was 50mM Tris.HCl, pH 7.5, 300mM KCl, and 5mM MgCl2.
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attached membrane ‘anchor’, and a ‘cargo’ molecule intended to
switch between this anchor and a free-solution state in response to
reversible phosphorylation (Fig. 3a). The membrane anchor had
three functional modules joined by flexible linkers: an N-terminal
CC-Di-A_S as the interaction module, the mCitrine fluorescent
protein for visualization, and a C-terminal decahistidine tag for
membrane attachment (CC-Di-A_S-mCitrine-H10). The cargo
molecule was the synthetic peptide CC-Di-B_RRS N-terminally
labeled with a fluorophore (Alexa Fluor 594, giving AF594-CC-Di-
B_RRS).
We characterized this system using supported lipid bilayers
(SLBs), as these flat, uniform membranes allowed us to quantify
membrane localization through fluorescence intensity. The SLBs
comprised DOPC doped with Ni-NTA-modified headgroup
lipids (DGS-NTA(Ni), for decahistidine attachment) plus ATTO
655-labeled DOPE (for imaging the lipid bilayer). After passivat-
ing the SLBs with BSA, they were incubated with the anchor
fusion protein for 30 min43. Membrane localization was con-
firmed by z-stacked confocal microscope images through the lipid
bilayer (Fig. 3a), which showed coincident peaks of fluorescence
intensity from the anchor protein and the labeled lipids
(Supplementary Fig. 5).
Next, the cargo peptide was added to the solution in the
unphosphorylated state. A peak of fluorescence intensity from the
cargo colocalized with those from the anchor protein and the
SLB, indicating that the cargo was successfully attached to the
membrane (Fig. 3c). To examine detachment of the cargo, and to
test that it interacts via CC formation with the anchor, we added
PKA and MgATP to the system and monitored the membrane-
localized fluorescence intensity of the two components over time.
The fluorescence intensity of the cargo at the membrane
decreased over time, indicating that the cargo was indeed being
released back into solution (Fig. 3b, d), whereas the fluorescence
intensity at the membrane from the anchor remained constant
over this time.
The change in cargo fluorescence intensity fitted to an
exponential decay to give a mean rate constant for membrane
detachment of 0.07 ± 0.03 min–1 (n= 3; Fig. 3b). This is ≈10
times faster than that observed in the HPLC and CD experiments.
We posit that this is because of the lower concentrations of
anchor and cargo used compared with the peptide concentrations
used in the foregoing experiments (1 µM vs 50 µM), which is
consistent with a shift in the reaction to the right in our proposed
scheme. Of course, other factors such as the presence of
fluorophores and other ‘modules’ attached to the CC peptides
may also alter the kinetics.
Finally, to confirm reversibility, we added λPP and MnCl2 to
the SLB system. This caused an increase in fluorescence intensity
from the cargo at the membrane, indicating reattachment to the
membrane (Fig. 3b, e). The intensity did not completely return to
the original value, which we suspected was due to one or more of
the following factors: (i) the continued presence of kinase; (ii)
dilution by the addition of reagents; (iii) the presence of Mn2+
ions; and (iv) degradation/adsorption to surfaces during mixing
and liquid handling. However, when the experiments were
repeated with the further step of adding a potent PKA inhibitor
after dephosphorylation no significant change in membrane
binding was observed, indicating that the continued presence of
kinase is unlikely to be a contributing factor (Supplementary
Fig. 6).
The above membrane-binding switch demonstrates that our
CC-based interaction module can be applied to reversibly target
molecules to membranes. In its present form, reliance on the non-
natural lipid DGS-NTA(Ni) limits application to synthetic
cellular mimics; however, it might be possible to implement this
mode of membrane targeting in natural cells by using alternative
anchoring means, for example, by using phosphoinositide-
binding domains or high-affinity membrane-binding peptides.
Mimicking the MinD switch allows reversible membrane tar-
geting through avidity. We targeted a further membrane-
binding switch inspired by the E. coli protein MinD. In vivo,
MinD forms a cytoplasmic, ADP-bound monomer, and a
membrane-associated, ATP-bound dimer. The latter is facilitated
by an amphipathic membrane-targeting sequence (MTS) that has
a low affinity for lipid membranes. ATP-induced dimerization
increases the effective affinity by colocalizing two MTSs, and thus
retains MinD at the membrane18,19. MinE binds the dimer to
enhance ATP hydrolysis, trigger dissociation to monomers, and
subsequent membrane detachment. This process cycles to form a
reaction-diffusion system that generates striking spatiotemporal
oscillations15.
We reasoned that a de novo designed switch of this type would
be powerful and broadly applicable for reversibly targeting
proteins to membranes. Further, such a switch would be fully
genetically encodable and would therefore be better suited to
in vivo applications than the preceding anchor/cargo system
described above that relies on non-natural lipids. Therefore, we
designed fusion proteins comprising the CC-Di-A_S and CC-Di-
B_RRS interaction modules, fluorescent protein labels (mVenus
and mApple, respectively), and MTSs (Fig. 4a). Preliminary
experiments using the MinD MTS indicated unfavorable electro-
static interactions with the CC modules, which we posit is related
to this MTS’s preference for highly negatively charged lipid
membrane. Therefore, we sought similar MTSs that rely entirely
on amphipathicity rather than electrostatics.
We identified the N-terminal ANCHR domain of the
ESCRTIII protein Snf7 as a potential candidate44. First, we tested
residues 1–13 of Snf7 from S. cerevisiae. Unexpectedly, the
resulting fusion proteins were truncated during protein expres-
sion. A fusion protein with the sequence from M. musculus was
not cleaved, but did not bind to membranes either, even up to 10
µM concentration. We reasoned that the weakened membrane
affinity was due to the absence of tryptophan residues in the MTS
motif (Fig. 4b). Therefore, we designed a ‘hybrid’ sequence,
hybSnf7(1–13), that combined features of the S. cerevisiae and M.
musculus MTSs (Fig. 4b).
Two fusion proteins were then engineered: hybSnf7(1–13)-
mVenus-H6-CC-Di-A_S (hereafter called ‘SwitchA’) and hybSnf7
(1–13)-mApple-H6-CC-Di-B_RRS (‘SwitchB’). Full-length pro-
teins were successfully isolated and purified. At 1 µM, both
proteins showed negligible membrane localization when added
individually to SLBs comprising DOPC doped with 0.1 mol%
ATTO655-DOPE (Fig. 4c, d). In contrast, when both proteins
were present at 1 µM each, they were strongly localized at the
membrane (Fig. 4e), indicative of avidity-enhanced membrane
binding by the dimer, as designed. The mVenus fluorescence was
diminished in this membrane-bound state, which we attribute to
FRET donation to mApple (calculated overlap integral: 4.07 ×
1015 M–1 cm–1 nm4, R0= 60 Å). Indeed, exciting mVenus only
gave an increase in fluorescence intensity in the mApple
sensitized emission (SE) channel upon heterocomplexation
(Supplementary Fig. 7a–c). Acceptor photobleaching of the
membrane-bound mApple supported this (Supplementary Fig. 8)
to provide further evidence for complexation and a functional
switch.
Finally, we tested release of the membrane-bound proteins by
switching them to the monomeric states through phosphoryla-
tion. Addition of PKA and MgATP led to a time-dependent
release of both proteins from the membrane (Fig. 4f, h). Kinetic
analysis yielded mean reaction rate constants of 0.10 ± 0.06 min–1
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for SwitchA and 0.10 ± 0.04 min–1 for SwitchB (both n= 6).
Moreover, the switch could be reversed: addition of λPP and
MnCl2 increased the membrane localization of both proteins
(Supplementary Fig 9), although this was more pronounced for
SwitchB than SwitchA. Again, the mApple SE channel diminished
upon phosphorylation (and dissociation of the complex), and
recovered after addition of λPP and dephosphorylation (Supple-
mentary Fig. 7d–e).
Discussion
In summary, we have developed a peptide switch based on a de
novo coiled-coil heterodimer and operated by phosphorylation
and dephosphorylation. We have combined this with natural
peptide and protein modules in fusion proteins that function as
reversible membrane-targeting switches. Two different modes of
membrane targeting are achieved. The first switches a ‘cargo’
fusion protein between solution and membrane-bound states via
Fig. 4 Oligomeric switching of membrane-binding state. a Schematic illustrating design and concept of switching with CC-Di-A_S colored red and CC-Di-
B_RRS blue. b Helical wheel diagram of hybSnf(1–13) and alignment of S. cerevisiae, M. musculus, and hybrid Snf7 sequences with conserved hydrophobic
residues highlighted in bold. c–f Representative orthogonal views of the xz plane of confocal microscopy image z-stacks with fluorescence intensity z-
profiles and illustrative schematics for SLBs with: c 1 µM SwitchA only, d 1 µM SwitchB only; e 1 µM each of SwitchA and SwitchB; and f 1 µM each of
SwitchA and SwitchB 1 h after MgATP and PKA were added. g Quantitation of membrane binding of SwitchA (orange) and SwitchB (pink) under the
conditions of panels c–f calculated from fluorescence z-profiles (n= 6 independent experiments; error bars represent mean ± S.D.; §p= 0.0011, t= 4.5167;
#p < 0.0001, t= 9.4307; †p= 0.0003, t= 5.3073; ‡p < 0.0001, t= 7.7144; unpaired two-tailed t test). h Representative kinetics of phosphorylation-
induced release of SwitchA and SwitchB from the SLB after the addition of MgATP and PKA at t= 0. Plotted fluorescence intensities (arbitrary units) are
peak intensities (i.e., membrane localized), determined from z-axis fluorescence intensity profiles such as those shown in c–f. Values were fitted with
the function y ¼ y0 þ ðy1  y0Þð1 ekxÞ. SLBs were DOPC with 0.1 mol% ATTO655-DOPE. The SLB buffer was 50mM Tris.HCl, pH 7.5, 300mM KCl,
and 5mM MgCl2. Six experimental replicates were performed.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21622-5 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:1472 | https://doi.org/10.1038/s41467-021-21622-5 |www.nature.com/naturecommunications 7
a permanent membrane-tethered ‘anchor’ protein. The second
mimics the membrane switch of the E. coli MinD protein19,
whereby the dimerization of monomers in solution leads to
membrane attachment through avidity enhancement of amphi-
pathic membrane-targeting sequences.
To implement mechanisms of biological pattern formation,
one next step would be to introduce additional elements to
generate feedback loops that control heterodimer association and
dissociation. This could recapitulate additional characteristics of
the MinCDE system, and thus create systems to generate oscil-
lations or patterns. Also, this type of membrane functionalization
has potential applications in biotechnology and synthetic biology.
For example, an ‘artificial cytoskeleton’ could be coupled to
membranes in cells to serve as scaffolds for biosynthesis14,45,46, or
used to stabilize and scaffold artificial membranes in protocells47.
The de novo nature of our CC-based modules makes them
suitable for applications in cells by minimizing the risk of cross-
talk or cryptic functions. Equally, their minimal, ground-up
construction is well-suited to introducing function in synthetic
cellular mimics. The peptide modules are small, comprising 28
residues each, making them relatively unobtrusive as tags in
fusion proteins. CCs have proven to be readily designable, as
evident from the diversity of different architectures of designed
CCs reported in the literature. Therefore, in principle, it should be
possible to design similar switches using higher stoichiometries,
such as trimers and tetramers48,49, which could increase sensi-
tivity and the range of structures into which these switches could
be incorporated. Furthermore, because the kinetics of
phosphorylation-induced dissociation are governed by the stabi-
lity of the coiled-coil complex, the rate of dissociation can be
tuned, most usefully through mutation or variation of the length
of the CC sequences, but also through temperature and peptide
concentration.
Aside from the already-discussed use in targeting membranes,
we anticipate that our CC-based switching modules will also be
useful for the construction of protein-based logic and orthogonal
signaling pathways in natural and synthetic cells40. This will
require the development of additional, orthogonal hetero-
oligomeric switch modules incorporating different peptide com-
binations and kinase/phosphatase recognition sites. Kinase/
phosphatase activity might be controlled transcriptionally, by
light50, or by small-molecules. Protein signaling circuitry and
control using protease-based logic gates39,51, or degron-coupled
protein switches52,53 have previously been described. The use of
phosphorylation and dephosphorylation as proposed here may
offer advantages in that it is a fully reversible and non-destructive
post-translational modification, as opposed to proteolytic clea-
vage or proteasomal degradation. It may also be possible to
interface directly with native signaling pathways. Further appli-
cations include the controlled assembly or disassembly of other
protein complexes to control gene and transcriptional
regulation37,54–56, and stimulus-responsive disassembly of artifi-
cial protein nanostructures57,58, for example to release an
encapsulated payload. Therefore, the switchable interaction
modules described herein have significant potential as compo-
nents in a variety of bioengineered and artificial systems to
introduce dynamics and control.
Methods
All values are reported as mean ± standard deviation unless otherwise stated.
Statistical significance is reported by p and t values calculated from two-tailed
unpaired t tests.
All chemicals, reagents, and oligonucleotides were from Sigma Aldrich unless
otherwise indicated.
ATP stock solution. ATP stock solutions were prepared from the ATP disodium
salt hydrate and titrated to pH 7.0 with 1M Tris base. ATP concentration was
confirmed spectrophotometrically at 259 nm using an extinction coefficient of
15,400 M–1 cm–1. Stocks were stored at –80 °C as single-use aliquots.
Enzymes. cAMP-dependent protein kinase (PKA) and lambda protein phospha-
tase (λPP) were purchased from New England Biolabs.
Peptide synthesis and purification. Peptides were synthesized using standard
microwave-assisted Fmoc solid-phase protocols on a CEM Liberty Blue automated
synthesiser coupled to an inline UV monitor. All peptides were prepared as C-
terminal amides at 0.1 mmol scale on Rink Amide ChemMatrix resin. Successive
amino acid coupling was achieved using diisopropylcarbodiimide (DIC)/6-chloro-
1-hydroxybenzotriazole (Cl-HOBt) coupling protocols, whilst Fmoc-cleavage was
performed by treatment with 20% morpholine in dimethyl formamide (DMF).
Upon completion, the resin-attached peptide was removed and, where appropriate,
the N-terminus acetylated by treatment with 3 eq. acetic anhydride and 4.5 eq N,N-
diisopropylethylamine (DIPEA) in DMF for 30 min. Owing to its expense, coupling
of AlexaFluor 594 carboxylic acid was performed at 5.5 µM scale with 1.1 eq
AlexaFluor 594 carboxylic acid, 1 eq. DIC and 1 eq. Cl-HOBt in DMF overnight.
Cleavage from the solid support was performed with a mixture of trifluoroacetic
acid (TFA)/triisopropylsilane/water (90/5/5, v/v/v). The cleavage solution was
reduced in volume to ∼5 ml by using a flow of nitrogen. Diethyl ether (45 ml) was
added to obtain a precipitate that was recovered by refrigerated centrifugation and
dissolved in 1:1 acetonitrile:water (10 ml) and lyophilized to yield a white solid.
Peptides were purified by reversed-phase HPLC, with a gradient of 20–80%
acetonitrile in water (each containing 0.1% TFA) over 45 min on a Vydac TP C18
column (10 µm particle, 22 × 250 mm). Fractions that contained pure peptide were
identified by analytical HPLC and matrix-assisted laser desorption/ionization–time
of flight (MALDI–TOF) mass spectrometry. Analytical HPLC was performed with
a Jasco 2000 series HPLC system with a Phenomenex Kinetex C18 column (5 μm
particle, 4.6 × 100 mm), monitored at 220 nm. The gradient was 20–80%
acetonitrile/water (each containing 0.1% TFA) over 16 min. MALDI–TOF mass
spectra were obtained on a Bruker UltraFlex MALDI–TOF mass spectrometer in
positive-ion reflector mode. Peptide solutions were spotted on a ground-steel target
plate with dihydroxybenzoic acid as the matrix. Calibration was conducted using
the ‘nearest neighbor’ method, with Bruker Peptide Calibration Standard II as the
reference masses.
Peptide concentrations were determined in solution by UV absorption
spectroscopy using the following extinction coefficients: ε280 nm (Trp) = 5690M–1
cm–1, ε280 nm (Tyr)= 1280M–1 cm–1.
Plasmids. pT7-CC-Di-A_S-mCitrine-H10 was produced by in vivo homologous
recombination59,60. The CC-Di-A_S-mCitrine-H10 coding sequence, incorporat-
ing flanking 18 bp sequences at 5′ and 3′ ends for homologous recombination into
pT7-αHL-D127N between start and stop codons was designed in silico and
obtained as synthetic dsDNA from Life Technologies. pT7-αHL-D127N was a kind
gift from Prof Hagan Bayley (University of Oxford)61,62. pT7-hybSnf7(1–13)-
mVenus-H6-CC-Di-A_S and pT7-hybSnf7(1–13)-mApple-H6-CC-Di-B_RRS
were produced in the same manner. Annotated amino acid sequences for all fusion
proteins are provided in the Supplementary Information and a list of primers used
is provided in Supplementary Table 1.
Expression and purification of CC-Di-A_S-mCitrine-H10. pT7-CC-Di-A_S-
mCitrine-H10 was transformed into chemically competent BL21(DE3)pLys cells
(Novagen/Merck Millipore), which were subsequently plated onto LB-agar under
carbenicillin and chloramphenicol antibiotic selection and incubated overnight at
37 °C. A single colony was selected to inoculate 20 mL of LB containing 50 µg mL–1
carbenicillin and 34 µg mL–1 chloramphenicol. This starter culture was grown
overnight (18 h) at 30 °C with shaking. The following morning, 1 L of Terrific
Broth (TB) containing 50 µg mL–1 carbenicillin and 34 µg mL–1 chloramphenicol
was inoculated with 20 mL of starter culture and grown at 37 °C with shaking until
it reached OD600= 0.6. The culture was then transferred to another shaker-
incubator at 18 °C and grown for 20 min before induction with 1 mM isopropyl-β-
D-1-thiogalactoside (IPTG). The induced culture was then grown overnight (18 h)
at 18 °C with shaking. Cells were harvested by centrifugation at 5000 × g and 4 °C
for 30 min in a TLA8.1000 rotor (Beckman Coulter). The supernatant was dis-
carded and the resulting cell pellet recovered and frozen at −20 °C until required.
To extract and purify the protein, the frozen cell pellet was thawed on ice, then
suspended in 20 mL lysis buffer (50 mM Tris.HCl, pH 7.5, 500 mM NaCl, 1 mM
dithiothreitol (DTT), 10 mM imidazole, and 0.1% (v/v) Triton X-100). In total,
7500 U of Serratia marcescens DNAse (SmDNAse, Biochemistry core facility of the
Max Planck Institute of Biochemistry) and 1 mgmL–1 (final concentration)
lysozyme from chicken egg white were added to the cell suspension, which was
then incubated on ice for 30 min. The lysed cells were sonicated in a water-ice bath
using a Branson Sonifier 250D, with 30 s pulses of 40% amplitude, followed by 30 s
periods of 0% amplitude (eight cycles were performed). The lysed cells were then
clarified by centrifugation at 40,000 × g and 4 °C for 45 min in a JA25.50 rotor
(Beckman Coulter). Following centrifugation, the supernatant was retained as the
cleared lysate.
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To purify CC-Di-A_S-mCitrine-H10, 1 mL Ni-NTA Superflow resin (Qiagen)
was equilibrated in binding buffer (50 mM Tris.HCl, pH 7.5, 500 mM NaCl, 1 mM
DTT, 10 mM imidazole, and 0.1% (v/v) Triton X-100). The equilibrated resin was
then added to the cleared lysate and the mixture was incubated at 4 °C for 1 h. The
mixture was then placed into a disposable glass column (Bio-Rad) and the flow-
through collected. The resin was then washed with 3 × 10 mL of wash buffer
(50 mM Tris.HCl, pH 7.5, 500 mM NaCl, 1 mM DTT, 20 mM imidazole). After
washing, protein was eluted using 10 × 0.5 mL elution buffer (35 mM Tris.HCl, pH
7.5, 350 mM NaCl, 0.7 mM DTT, 300 mM imidazole). Fractions were analyzed by
SDS-PAGE and UV-Vis spectroscopy.
Peak fractions were pooled and further purified by size exclusion chromatography
using a HiLoad 16/600 Superdex 75 pg column (GE Healthcare) equilibrated in
storage buffer (50mM Tris.HCl, pH 7.5, 100mM NaCl, 1mM DTT, 10% glycerol).
The column was run isocratically with a flow rate of 0.5mLmin–1 using an Äkta Pure
chromatography system (GE Healthcare). Peak fractions were analyzed by SDS-
PAGE and UV-Vis spectroscopy, pooled, aliquoted, and flash frozen in liquid
nitrogen before being stored at −80 °C. The purified protein was further analyzed by
LC-MS to confirm correct mass and purity (expected mass: 34,690.5586; observed
mass: 34669.3394). Protein concentration was determined by fluorescence absorbance
of the mCitrine label (ɛ515(mCitrine) = 69,000M–1 cm–1).
Expression of hybSnf7(1–13)-mVenus-H6-CC-Di-A_S and hybSnf7(1–13)-
mApple-H6-CC-Di-B_RRS. pT7-hybSnf7(1–13)-mVenus-H6-CC-Di-A_S and
pT7-hybSnf7(1–13)-mApple-H6-CC-Di-B_RRS were each transformed into che-
mically competent BL21(DE3)pLysS cells and expression cultures were grown to
OD600= 1.0 and then induced under the same conditions as above. The induced
cultures were grown overnight (18 h) at 18 °C with shaking. Cells were harvested
and stored as above.
Purification of hybSnf7(1–13)-mVenus-H6-CC-Di-A_S. The frozen cell pellet as
described above was thawed on ice then suspended in 25 mL lysis buffer (as above).
In total, 7500 U of SmDNAse, 1 mgmL–1 (final concentration), and a protease
inhibitor cocktail tablet (Roche cOmplete EDTA-free) were added to the cell
suspension, which was then incubated on ice for 30 min. The lysed cells were
sonicated and clarified as above.
hybSnf7(1–13)-mVenus-H6-CC-Di-A_S was purified from the cleared lysate
using Ni-NTA affinity chromatography as described above. Peak fractions were
pooled and concentrated (Amicon Ultra-15 with 10 kDa NMWL), before being
further purified by size exclusion chromatography using a Superdex 75 10/300 GL
column (GE Healthcare) equilibrated in storage buffer (50mM Tris.HCl, pH 7.5,
100mM NaCl, 1 mM DTT, and 10% glycerol). The column was run isocratically
with a flow rate of 0.4 mLmin–1 using an Äkta Pure chromatography system (GE
Healthcare). The protein eluted as two peaks, with the first at 10.8 mL
corresponding to the full-length protein and the second at 11.5mL corresponding to
the truncated protein, as confirmed by SDS-PAGE and LC-MS. The 10.8-mL peak
was collected, aliquoted, and flash frozen in liquid nitrogen before being stored at
−80 °C. The observed mass obtained by LC-MS was 34,792.8122 (expected mass:
34,793.8477). Protein concentration was determined by fluorescence absorbance of
the mVenus label (ε515(mVenus)= 104,000M–1 cm–1).
Purification of hybSnf7(1–13)-mApple-H6-CC-Di-B_RRS. The cleared lysate was
prepared in the same manner as for hybSnf7(1–13)-mVenus-H6-CC-Di-A_S. To
purify hybSnf7(1–13)-mApple-H6-CC-Di-B_RRS from the cleared lysate, 1 mL Ni-
NTA Superflow resin (Qiagen) was equilibrated in binding buffer (50mM Tris.HCl,
pH 7.5, 500mM NaCl, 1mM DTT, 10mM imidazole, 0.1% (v/v) Triton X-100). The
equilibrated resin was then added to the cleared lysate and the mixture was incubated
at 4 °C for 1 h. The mixture was then placed into a disposable glass column (Bio-Rad)
and the flow-through collected. The resin was then washed with 3 × 10mL of high salt
wash buffer (50mM Tris.HCl, pH 7.5, 1M NaCl, 1 mM DTT, 20mM imidazole),
followed by 2 × 10mL of wash buffer (50mM Tris.HCl, pH 7.5, 500mM NaCl, 1mM
DTT, 20mM imidazole). After washing, protein was eluted using 8 × 0.5mL elution
buffer (35mM Tris.HCl, pH 7.5, 350mM NaCl, 0.7mM DTT, 300mM imidazole).
Fractions were analyzed by SDS-PAGE and UV-Vis spectroscopy.
Peak fractions were pooled before being further purified by ion exchange
chromatography. The pooled fractions were diluted 10-fold into Buffer A (50 mM
Tris.HCl, pH 7.5, 50 mM NaCl, 1 mM DTT). The diluted protein was then loaded
onto a 1-mL HiTrap SP HP column (GE Healthcare) that had been equilibrated in
Buffer A. The small fraction of truncated protein present did not bind the column
and was discarded in the flow-through. The column was washed with 10 mL Buffer
A and then protein was eluted by applying a gradient of 0–50% Buffer B (50 mM
Tris.HCl, pH 7.5, 1 M NaCl, 1 mM DTT) over 20 column volumes. The full-length
protein eluted at ~12% Buffer B. Peak fractions were collected and pooled and
analyzed by SDS-PAGE and LC-MS. The observed mass was 34,884.0274
(expected: 34,885.5898). Sterile 50% glycerol was added to the pooled purified
protein to a final concentration of 10% glycerol. The protein was then aliquoted
and flash frozen in liquid nitrogen before being stored at –80 °C. Protein
concentration was determined by fluorescence absorbance of the mApple label
(ε568(mApple)= 75,000M–1 cm–1).
Circular dichroism spectroscopy. Circular dichroism spectroscopy was per-
formed on JASCO J-715 and J-810 spectropolarimeters (JASCO) fitted with Peltier
temperature controllers. Peptides were dissolved in PBS buffer and measured in
quartz cuvettes with 1 mm pathlength.
Thermal denaturation experiments were performed with a 5–90 °C temperature
ramp at a rate of 40 °C h–1. Full spectra were determined at 5 °C intervals and CD
at 222 nm was measured at 1 °C intervals (1 nm interval, 1 nm bandwidth, 16 s
response). Tm values were determined from the second derivative of the thermal
denaturation curve.
Phosphorylation reactions were performed in PBS with the addition of 10 mM
MgCl2 and 1 mM ATP. PKA (2500 U) was added to a reaction volume of 300 µL to
initiate the reaction. CD at 222 nm was measured over time for the duration of the
reaction (10 s intervals). Dephosphorylation reactions were performed in 50 mM
Tris.HCl, pH 7.5, 150 mM NaCl, with peptide concentrations of 10 µM each. To
begin dephosphorylation, 1 mM MnCl2 and 4000 U lambda protein phosphatase
were added to the reaction volume of 300 µL.
Analytical HPLC. HPLC analysis of peptides was performed on an Agilent 1260
Infinity II HPLC System (Agilent Technologies) using a Kinetex C18 column
(150 × 3mm, 2.6 µm beads, Phenomenex Inc.). A gradient of water/0.1% TFA to
acetonitrile/0.08% TFA (15% acetonitrile/0.08% TFA from 0 to 2 min, 15–60%
from 2 to 45 min, and 60–90% from 45 to 60 min) was used at 420 µL/min flowrate,
with UV detection at 214 nm. Injection volume was 20 µL. Agilent Open LAB CDS
Chemstation Edition (software revision C.01.08) was used for data integration and
analysis. Chromatograms were processed (baseline subtraction and normalization)
and plotted in a Jupyter notebook.
Phosphorylation reactions were performed in PBS with the addition of 10 mM
MgCl2 and 1 mM ATP. PKA (5000 U) was added to a reaction volume of 600 µL to
initiate the reaction. The reaction temperature was maintained at 25 °C throughout.
In all, 60 µL aliquots were taken at specified time intervals, to which 20 mM
EDTA was added (final concentration) to stop the reaction. Aliquots were stored
at −20 °C until required.
Supported lipid bilayer experiments. Supported lipid bilayers (SLBs) were
formed by the fusion of small unilamellar vesicles (SUVs) on glass coverslips
(Menzel #1.5, 24 × 24 mm). The coverslips were cleaned by washing in ultrapure
water, followed by absolute ethanol before drying under a stream of nitrogen. Once
dry, the coverslips were cleaned in an oxygen plasma cleaner (0.3 mbar O2, 50%
power for 30 s, Diener Zepto, and Diener electronic GmbH). A buffer reservoir was
formed above the coverslips by attaching the tubular part of 0.5 mL micro-
centrifuge tubes to the glass surface with optical adhesive (Norland Optical
Adhesive 68, Norland Products). To prepare SUVs, lipids (DOPC with 2 mol%
DGS-NTA(Ni) (Avanti Polar Lipids, Inc.) and 0.1 mol% ATTO655-DOPE (ATTO-
TEC GmbH)) were dissolved and mixed in chloroform and then dried under a
gentle stream of nitrogen before drying under vacuum for 1 h. The dried lipid film
was rehydrated in SLB buffer (50 mM Tris.HCl pH 7.5, 300 mM KCl, and 5 mM
MgCl2) at a concentration of 1 mgmL–1, before being vortexed and sonicated (bath
sonicator, Branson) until clear. To form SLBs, the prepared SUVs were diluted to
0.1 mg mL–1 in 200 µL SLB buffer and placed atop the prepared glass coverslip
surface in the buffer reservoir. CaCl2 was added to a final concentration of 3 mM to
promote SUV fusion with the glass surface. After 30 min incubation at room
temperature, the glass surface was washed with 10 × 200 µL SLB buffer to remove
unfused SUVs. SLBs were passivated by incubation with 1 mgmL–1 bovine serum
albumin (BSA) for 1 h at room temperature to reduce non-specific binding. This
concentration was then reduced to 0.4 mg/mL for subsequent experimental steps.
To couple anchor protein (DiA_S-mCitrine-H10) to SLBs, SLBs were incubated
with 1 µM DiA_S-mCitrine-H10 for 30 min. Cargo peptide (Alexa 594-Di-B_RRS)
was then added to a final concentration of 1 µM.
To detach cargo peptide, MgATP (10 mM MgCl2, 1 mM ATP, final
concentrations) was added to the SLBs followed by 500 U protein kinase A (PKA/
cAMP-dependent protein kinase, New England Biolabs). To re-attach cargo
peptide, 1 mM MnCl2 (final concentration) and 400 U lambda protein phosphatase
(λPP) were added to SLBs.
For experiments with hybSnf7(1–13)-mVenus-H6-DiA_S and hybSnf7(1–13)-
mApple-H6-Di-B_RRS, SLBs were prepared as above, but with the SLBs
comprising DOPC (Avanti Polar Lipids, Inc.) with 0.1 mol% ATTO655-DOPE
(ATTO-TEC GmbH). For FRET experiments, the ATTO655-DOPE was omitted.
Proteins were then added individually or together at 1 µM final concentration. To
detach proteins, MgATP (10 mM MgCl2, 1 mM ATP, final concentrations) was
added to the SLBs followed by 500 U protein kinase A (PKA/cAMP-dependent
protein kinase, New England Biolabs). To re-attach proteins, 1 mM MnCl2 (final
concentration) and 400 U lambda protein phosphatase (λPP) were added to SLBs.
Microscopy and image analysis. Imaging was performed on a Zeiss LSM780
confocal microscope using a Zeiss C-Apochromat 40X/1.20 water-immersion
objective (Carl Zeiss), and a Zeiss LSM800 confocal microscope also using a Zeiss
C-Apochromat 40X/1.20 water-immersion objective. mCitrine and mVenus were
excited at 488 nm, mApple at 561 nm, and ATTO 655 at 633 nm (or 640 nm for the
LSM800). In the case of multi-color imaging, each color was excited using separate
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imaging tracks to avoid cross-talk. For the measurement of stimulated emission by
FRET, excitation was performed at 488 nm and emission was measured with a 600-
nm high-pass filter. Images were obtained using a pinhole diameter of 1 Airy unit, a
resolution of 512 × 512 pixels, and a scan rate of 1.58 µs (LSM780) or 1.03 µs
(LSM800) per pixel. The temperature at the microscope stage was 21 °C.
To determine the degree of membrane localization, z-stacks of images (where z
is the axis perpendicular to the plane of the SLB) were obtained by confocal
microscopy. Image analysis was performed using Fiji63 Where orthogonal xz plane
images are presented, the brightness and contrast of these images has been adjusted
uniformly to aid visibility.
For the analysis of SLB membrane-localized fluorescence intensity over time,
time series of z-stacked images were analyzed using a custom ImageJ macro
(available at https://github.com/leonharrington/zanalyzer). At each time point, the
macro generates a z-profile from the mean fluorescence intensity from each
constituent image of the z-stack. The peak intensity value from each profile is then
plotted against time to give the resulting fluorescence intensity time course for the
membrane-localized fraction.
To quantitate membrane localization, peak areas were calculated by integrating
the peaks of z-profiles generated from confocal microscopy images in OriginPro
2018. The Peak Analyzer function was used with manual baseline subtraction to
correct for the fluorescence from the bulk solution of the SLB.
Kinetic analysis. Data plotting and fitting was performed with Graphpad Prism 8.
For the HPLC experiments, reaction curves were generated by plotting integrated
peak area versus reaction time. The curves were then fitted by non-linear regression
to the equations:
y ¼ y0 þ y1  y0
 
1 ekx  ð2Þ
and
y ¼ y0  ekx ð3Þ
for product formation and substrate consumption, respectively. Fitted values are
reported for three independent experiments.
Reaction curves obtained in CD and SLB experiments were fitted by non-linear
regression to Eq. (2). Fitted values are reported as mean ± standard deviation from
the indicated number of experimental replicates.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The datasets generated during and/or analyzed during the current study are available
from the corresponding author on reasonable request.
Code availability
The custom ImageJ macro used to analyze SLB membrane-localized fluorescence
intensity over time from time series of z-stacked images is available at https://github.
com/leonharrington/zanalyzer (DOI: 10.5281/zenodo.4495771) or from the
corresponding author on request.
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